Targeting the RAS Signaling Pathway in Malignant Hematologic Diseases

Publisher： Bentham Science Publishers

E-ISSN： 1873-5592|8|2|217-235

ISSN： 1389-4501

Source： Current Drug Targets, Vol.8, Iss.2, 2007-02, pp. : 217-235

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Agents Targeting Ras Signaling Pathway

By  

Current Pharmaceutical Design, Vol. 8, Iss. 25, 2002-11 ,pp. : 2259-2267

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting the PDGF Signaling Pathway in the Treatment of Non-Malignant Diseases

By Heldin Carl-Henrik  

Journal of Neuroimmune Pharmacology, Vol. 9, Iss. 2, 2014-03 ,pp. : 69-79

Springer Publishing Company

Access to resources Recommend Favorite

Targeting the Notch signaling pathway in autoimmune diseases

By Ma Daoxin   Zhu Yuanchao   Ji Chunyan   Hou Ming  

Expert Opinion on Therapeutic Targets, Vol. 14, Iss. 5, 2010-05 ,pp. : 553-565

Informa Healthcare

Access to resources Recommend Favorite

Targeting RAS Signaling Pathways in Juvenile Myelomonocytic Leukemia

By  

Current Drug Targets, Vol. 8, Iss. 6, 2007-06 ,pp. : 715-725

Bentham Science Publishers

Access to resources Recommend Favorite

Ras Signaling Pathway Proteins as Therapeutic Targets

By  

Current Pharmaceutical Design, Vol. 7, Iss. 16, 2001-11 ,pp. : 1581-1594

Bentham Science Publishers

Access to resources Recommend Favorite